Rheumatic diseases in pregnancy.
The effects of pregnancy on the clinical course of the rheumatic diseases is not only variable but often unpredictable. Disease activity at the onset of pregnancy will have great bearing on fetal outcome. Thus the use of potentially harmful drug combinations in pregnancy has to be weighed against theoretical teratogenic effects. This review outlines some of these dilemmas.
Nicholas
N S
NS
Queen Charlotte's Hospital, London.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000628:therapy; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D011256:Pregnancy Outcome; D012216:Rheumatic Diseases / Q000628:therapy; D012595:Scleroderma, Systemic / Q000628:therapy; D013167:Spondylitis, Ankylosing / Q000628:therapy